An HIV clinical trial is a research study that tests whether a new medicine, treatment approach, or prevention strategy works in real people. Unlike laboratory experiments, clinical trials involve actual participants—sometimes hundreds or thousands—who volunteer to test treatments under careful medical supervision. These trials are how we've developed nearly every HIV medication available today, from the first antiretroviral drugs in the 1990s to modern long-acting injectables that patients receive just a few times per year.
Learn About Paying Your FGUA Bill Online →
Clinical trials follow strict rules set by the FDA and institutional review boards (IRBs), which are committees that protect participant safety. Before any trial recruits a single person, researchers must prove the treatment has shown promise in earlier laboratory and animal testing. Throughout the trial, doctors monitor participants closely for side effects and track whether the treatment actually works. This process can take years, but it's designed to answer genuine medical questions: Does this new approach prevent infection better than current methods? Do these new pills have fewer side effects? Can this strategy help people whose virus has stopped responding to other drugs?
For people living with HIV, clinical trials have historically been the only way to access cutting-edge treatments before they're widely prescribed. For people without HIV, prevention trials (called PrEP trials) test whether medicines taken before potential exposure actually stop infection. Research trials also investigate questions about managing side effects, simplifying pill regimens, or using HIV treatment as prevention (sometimes called "U=U" or undetectable equals untransmittable).
Practical takeaway: Before searching for trials in your area, understand that trials exist to answer specific research questions—they're not just alternative treatment centers. Knowing what question a particular trial is trying to answer helps you decide if it fits your situation.
HIV clinical trials operate through several types of research sites. University medical centers and large hospitals often run trials because they have research departments and access to diverse patient populations. Smaller community health centers, particularly those focusing on HIV care, also conduct trials because they work closely with people living with HIV and communities most affected by the virus. Private research organizations hire staff specifically to run trials, often operating multiple sites across a region or nationwide. Each site has a research team: a principal investigator (usually a doctor), research coordinators who manage day-to-day activities, and nursing staff who handle medical procedures.
Free Guide to Pay by Plate Illinois Billing →
The companies developing new HIV drugs fund many trials, but so do the National Institutes of Health (NIH), foundations focused on HIV research, and international organizations. This funding source matters because it affects which treatments get studied. For instance, large pharmaceutical companies typically fund trials for brand-new medications they hope to sell. The NIH often funds trials comparing existing treatments or studying how to reach underserved populations. Community-based organizations sometimes run trials focused on specific groups—trials specifically designed for transgender women with HIV, trials in rural areas, or trials focused on people with substance use disorders.
When you contact a trial site, you'll interact with research coordinators before ever seeing a doctor. These coordinators explain what participation involves, answer questions about time commitments and procedures, and handle scheduling. They're not clinical providers, so they follow scripts and protocols—they can't modify trial rules or make individual exceptions, but they can clarify exactly what the trial requires.
Practical takeaway: Different sites have different populations and specialties. A trial at a community health center serving predominantly Black participants might run differently than one at a university hospital, and understanding the site type helps you know what to expect.
The most direct resource is ClinicalTrials.gov, a database run by the National Institutes of Health that lists virtually every HIV clinical trial happening in the United States. You can search by your zip code, city, or state to find trials recruiting in your area. The site lets you filter by trial phase (early testing versus larger studies), trial type (treatment, prevention, or other), and specific keywords. If you search "HIV prevention" in New York, for example, you'll see every PrEP trial currently recruiting in New York state. Each trial listing includes the site location, contact information, and a summary of what participants do.
Free Guide to Mold Removal Methods for Walls →
Beyond the NIH database, several organizations maintain their own trial registries. AVAC (Global Advocacy for HIV Prevention) runs a prevention trials database specifically focused on HIV prevention studies, which is helpful if you're interested in PrEP or vaccine trials rather than treatment studies. The AMFAR organization sometimes lists trials in their resource sections. Local AIDS service organizations and community health centers often know about trials recruiting locally—these organizations work closely with trial sites and can tell you which studies are currently active in your region.
If you have HIV and work with a regular HIV care provider, that clinic almost certainly has information about trials you might join. Many medical practices screen their patients during routine visits, asking who might be interested in research participation. If your doctor mentions a trial, you're hearing about one specifically designed with people like you in mind. Prevention trials recruit through different channels: sexual health clinics, LGBTQ community centers, colleges and universities, and online outreach to communities at higher risk for HIV.
Geographic searches sometimes show trials further away than you'd prefer. A trial in the nearest major city might be worth considering if it's studying something highly relevant to you, but understand that multi-visit trials require significant travel commitment. Some trials bus participants or provide travel reimbursement, though you'd need to ask directly.
Practical takeaway: Start with ClinicalTrials.gov and your existing healthcare provider, then expand to disease-specific organizations if you're not finding what you're looking for in your immediate area.
Clinical trial participation isn't one standard experience—it varies dramatically between trials. Some trials require monthly office visits for two years; others involve quarterly visits over five years. Some trials test a pill you take daily; others test long-acting injectables given every few months. Some require HIV tests every month; others test every three months. Understanding the specific schedule and requirements for each trial is essential before you commit, because the burden of participation differs enormously.
How to Delete Your Fitbit Account Guide →
Treatment trials for people living with HIV typically involve a baseline visit where researchers establish your starting point—your current viral load, CD4 count, and overall health status. You'll then take the new medication (or in some trials, continue your current medication while being closely monitored). Visits include blood draws, questionnaires about side effects, and discussions about how you're tolerating the medication. If you experience side effects, the trial protocol dictates how researchers respond—they might lower your dose, switch you to a different medication within the trial, or withdraw you from the trial entirely. You don't necessarily get to choose; the protocol determines this.
Prevention trials work differently. A PrEP trial might involve enrolling people considered at higher risk for HIV, teaching them to take the prevention medication consistently, testing them for HIV regularly (to make sure the medication worked and they didn't acquire HIV), and tracking side effects. Vaccine trials involve receiving injections on a schedule, then regular HIV testing afterward to see if your body developed immunity. These typically require less frequent visits than treatment trials but run longer—sometimes three or four years—because researchers need to track whether protection lasts.
Many trials require you to maintain certain behaviors or restrictions. You might need to agree to use condoms, avoid certain other medications, maintain stable housing, or remain in contact with the research site. Some trials restrict heavy alcohol use or drug use. These requirements exist because researchers need to isolate what the medication does versus what other factors might affect outcomes. If you can't or won't follow these restrictions, you won't be a good fit for that particular trial.
You'll receive written informed consent documentation—sometimes very long documents explaining risks, benefits, procedures, and your rights. You're legally entitled to take this home, review it, ask questions, and think about it before signing. Never sign consent forms at your first appointment unless you've had time to read and understand them.
Practical takeaway: Before contacting a trial, look at the time commitment and procedures in the trial summary. If the schedule doesn't fit your life or the procedures concern you, that particular trial probably isn't right for you—and there may be others that are.
The initial contact is usually brief and informational. You might call, email, or fill out a contact form on a research website. You'll provide basic information: your name, how to reach you, and often your HIV status or prevention needs (
Learn How to Grow Sweet Corn at Home →
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.